Iron-induced carcinogenesis: The role of redox regulation

Free Radical Biology and Medicine

Volumn 20, Issue 4, 1996, Pages 553-566

  Toyokuni, Shinya ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Asbestosis; Carcinogenesis; Free radicals; Hemochromatosis; Iron; Lipid peroxidation; Neoplasm; Oxidative DNA damage; Reactive oxygen species; Redox

Indexed keywords

FREE RADICAL; IRON; REACTIVE OXYGEN METABOLITE;

ASBESTOSIS; CARCINOGENESIS; CYTOTOXICITY; DNA DAMAGE; DRUG INDUCED DISEASE; HEMOCHROMATOSIS; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN TRANSPORT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSFERRIN BLOOD LEVEL;

MAMMALIA;

EID: 0029932034     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(95)02111-6     Document Type: Review

References (180)

1. Halliwell, B.; Gutteridge, J. M. C. Free radicals in biology and medicine. Oxford: Clarendon Press; 1989.
2. Wriggleworth, J. M.; Baum, H. The biochemical function of iron. In: Jacobs, A.; Worwood, M. eds. Iron in biochemistry and medicine, II. London: Academic Press; 1980:29-86.
3. deDuve, C. Blue print for a cell: The nature and origin of life. Burlington, NC: Neil Patterson Publishers; 1991:166-168.
4. Fenton, H. J. H. Oxidation of tartaric acid in presence of iron. J. Chem. Soc. 65:899-910; 1894.
5. Gutteridge, J. M. C.; Rowley, D. A.; Halliwell, B. Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts: Detection of 'catalytic' iron and anti-oxidant activity in extracellular fluids. Biochem. J. 206:605-609; 1982.
6. Gajewski, E.; Aruoma, O. I.; Dizdaroglu, M.; Halliwell, B. Bleomycin-dependent damage to the bases in DNA is a minor side reaction. Biochemistry 30:2444-2448; 1991.
7. Ferrali, M.; Ciccoli, L.; Comporti, M. Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation. Biochem. Pharmacol. 38:1819-1825; 1989.
8. Lippard, S. J.; Berg, J. M. Principles of bioorganic chemistry. Mill Valley, CA: University Science Books; 1994.
9. Halliwell, B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates: Is it a mechanism for hydroxyl radicals production in biochemical systems? FEBS Lett. 92:321-326; 1978.
10. Gutteridge, J. M. C. Superoxide-dependent formation of hydroxyl radicals from ferric-complexes and hydrogen peroxide: An evaluation of fourteen iron chelators. Free Radic. Res. Commun. 9:119-125; 1990.
11. Graf, E.; Mahoney, J. R.; Bryant, R. G.; Eaton, J. W. Iron-catalyzed hydroxyl radical formation: Stringent requirement for free iron coordination site. J. Biol. Chem. 259:3620-3624; 1984.
12. Inoue, S.; Kawanishi, S. Hydroxyl radical production and human DNA damage induced by ferric nitrilotriacetate and hydrogen peroxide. Cancer Res. 47:6522-6527; 1987.
13. Toyokuni, S.; Sagripanti, J.-L. Iron-mediated DNA damage: Sensitive detection of DNA strand breakage catlyzed by iron. J. Inorg. Biochem. 47:241-248; 1992.
14. Mitsui, A.; Hirakawa, T.; Yodoi, J. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem. Biophys. Res. Commun. 186:1220-1226; 1992.
15. Fujii, S.; Nanbu, Y.; Nonogaki, H.; Konishi, I.; Mon, T.; Masutani, H.; Yodoi, J. Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervecal squamous epithelium. Cancer 68:1583-1591; 1991.
16. Nakamura, H.; Masutani, H.; Tagaya, Y.; Yamauchi, A.; Inamoto, T.; Nanbu, Y.; Fujii, S.; Ozawa, K.; Yodoi, J. Expression and growth-promoting effect of adult T-cell leukemia-derived factor: A human thioredoxin homologue in hepatocellular carcinoma. Cancer 69:2091-2097; 1992.
17. Yodoi, J.; Tursz, T. ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: Involvement in lymphocyte immortalization by HTLV-I and EBV. Adv. Cancer Res. 57:381-411; 1991.
18. Matsuda, M.; Masutani, H.; Nakamura, H.; Miyajima, S.; Yamauchi, A.; Yonehara, S.; Uchida, A.; Irimajiri, K.; Horiuchi, A.; Yodoi, J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol. 147:3837-3841; 1991.
19. Chae, H. Z.; Kim, I.-H.; Kim, K.; Rhee, S. G. Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J. Biol. Chem. 268:16815-16821; 1993.
20. Yim, M. B.; Chae, H. Z.; Rhee, S. G.; Boon Chock, B.; Stadtman, E. R. On the protective mechanism of the thiol-specific antioxidant enzyme against the oxidative damage of biomacromolecules. J. Biol. Chem. 269:1621-1626; 1994.
21. Hershko, C.; Peto, T. E. A. Anotation: Non-transferrin plasma iron. Br. J. Haematol 66:149-151; 1987.
22. Reynolds, L. G.; Klein, M. Iron-poisoning: A preventable hazard of childhood. S. Afr. Med. J. 67:680-683; 1985.
23. Burkitt, M. J.; Mason, R. P. Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload: An ESR spin-trapping investigation. Proc. Natl. Acad. Sci. USA 88:8440-8444; 1991.
24. Buchannan, W. M. Shock in Bantu siderosis. Am. J. Clin. Pathol. 55:401-406; 1971.
25. Murray, J. A. Survival and desfferioxamine in thalassemia major. Br. Med. J. 284:1401; 1982.
26. Halliwell, B. Ascorbic acid, iron overload, and desferrioxamine. Br. Med. J. 285:296; 1982.
27. Herbert, V.; Shaw, S.; Jayatilleke, E.; Stopler-Kasdan, T. Most free-radical injury is iron-related: It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by deferoxamine and apoferritin. Stem Cells 12:289-303; 1994.
28. Haber, F.; Weiss, J. The catalytic decomposition of hydrogen peroxide by iron salts. Proc. R. Soc. Lond. [A] 147:332-351; 1934.
29. Bannister, J. V.; Bannister, W. H.; Hill, H. A. O.; Thornalley, P. J. Enhanced production of hydroxyl radicals by the xanthine-xanthine oxidase reaction in the presence of lactoferrin. Biochem. Biophys. Acta 715:116-120; 1982.
30. Motohashi, N.; Mori, I. Superoxide-dependent formation of hydroxyl radical catalysed by transferrin. FEBS Lett. 157:197-199; 1983.
31. O'Connell, M. J.; Halliwell, B.; Moorehouse, C. R.; Aruoma, O. I.; Baum, O. I.; Peters, T. J. Formation of hydroxyl radicals in the presence of ferritin and haemosiderin: Is haemosiderin formation a biological protective mechanism? Biochem. J. 234:727-731; 1986.
32. Biemond, P.; van Eijk, H. G.; Swaak, J. G.; Koster, J. F. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. J. Clin. Invest. 73:1576-1579; 1984.
33. Thomas, C. E.; Morehouse, L. A.; Aust, S. D. Ferritin and superoxide-dependent lipid peroxidation. J. Biol. Chem. 260:3275-3280; 1985.
34. Ozaki, M.; Kawabata, T.; Awai, M. Iron relesae from haemosiderin and production of iron-catayzed hydroxyl radicals in vitro. Biochem. J. 250:589-595; 1988.
35. Babior, B. M.; Kipnes, R. S.; Curnutte, J. T. Biological defence mechamism: The production by leukocytes of superoxide, a potent bactericidal agent. J. Clin. Invest. 52:741-744; 1973.
36. McCord, J. M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:159-163; 1985.
37. Jacobs, A. Low molecular weight intracellular iron transport compounds. Blood 50:433-439; 1977.
38. Mulligan, M.; Althaus, B.; Linder, M. C. Nonferritin, nonheme iron pools in rat tissues. Int. J. Biochem. 18:791-798; 1986.
39. Weaver, J.; Pollack, S. Low-Mr iron isolated from guinea pig reticulocytes as AMP-Fe and ADP-Fe complexes. Biochem. J. 261:787-792; 1989.
40. Samuni, A.; Aronovich, J.; Godinger, D.; Chevion, M.; Czapski, G. On the toxicity of vitamin C and metal ions: A site-specific Fenton mechanism. Eur. J. Biochem. 137:119-124; 1983.
41. Chevion, M. A site-specific mechanism for free radical induced biological damage: The essential role of redox-active transtion metals. Free Radic. Biol. Med. 5:27-37; 1988.
42. Conrad, M. E.; Uzel, C.; Berry, M.; Latour, L. Ironic catastrophes: One's food-anather's poison. Am. J. Med. Sci. 307:434-437; 1994.
43. Stevens, R. G.; Jones, D. Y.; Micozzi, M. S.; Taylor, P. R. Body iron stores and the risk of cancer. N. Engl. J. Med. 319:1047-1052; 1988.
44. Stevens, R. G.; Beasley, R. P.; Blumberg, B. S. Iron-binding proteins and risk of cancer in Taiwan. J. Natl. Cancer Inst. 76:605-610; 1986.
45. Selby, J. V.; Friedman, G. D. Epidemiologic evidence of an association between body iron stores and risk of cancer. Int. J. Cancer 41:677-682; 1988.
46. Hann, H.-W. L.; Kim, C. Y.; London, W. T.; Blumberg, B. S. Increased serum ferritin in chronic liver disease: A risk factor for primary hepatocellular carcinoma. Int. J. Cancer 43:376-379; 1989.
47. Nelson, R. G.; Davis, F. G.; Sutter, E.; Sobin, L. H.; Kikendall, J. W.; Bowen, P. Body iron stores and risk of colonic neoplasia. J. Natl. Cancer Inst. 86:455-460; 1994.
48. Stevens, R. G.; Graubard, B. I.; Micozzi, M. S.; Neriishi, K.; Blumberg, B. S. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int. J. Cancer 56:364-369; 1994.
49. Knekt, P.; Reunanen, H.; Takkunen, H.; Aromaa, A.; Heliovaara, M.; Hakulinen, T. Body iron stores and risk of cancer. Int. J. Cancer 56:379-382; 1994.
50. Nelson, R. L. Dietary iron and colorectal cancer risk. Free Radic. Biol. Med. 12:161-168; 1992.
51. Weinberg, E. D. Association of iron with colorectal cancer. Biometals 7:211-216; 1994.
52. Akiba, S.; Neriishi, K.; Blot, W. J.; Kabuto, M.; Stevens, R. G.; Kato, H.; Land, C. E. Serum ferritin and stomach cancer risk among a Japanese population. Cancer 67:1707-1712; 1991.
53. Evans, J. E.; D'angio, G. J.; Propert, K.; Anderson, J.; Hann, H.-W. L. Prognostic factors in neuroblastoma. Cancer 59:1853-1859; 1987.
54. Hann, H.-W. L.; Lange, B.; Stahlhut, M. W.; McGlynn, K. A. Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease. Cancer 66:313-316; 1990.
55. Potaznic, D.; Groshen, S.; Miller, D.; Bagin, R.; Bhalla, R.; Schwartz, M.; de Sousa, M. Association of serum iron, serum transferrin saturation, and serum ferritin with survival in acute lymphocytic leukemia. Am. J. Pediatr. Hematol/Oncol. 9:350-355; 1987.
56. Cotran, R. S.; Kumar, V.; Robbins, S. L. Robbins pathologic basis of disease. 5th ed. Philadelphia, PA: W. B. Saunders; 1989:861-863.
57. Niedereau, C.; Fischer, R.; Sonnenberg, A.; Stremmel, W.; Trampisch, H. J.; Strohmyer, G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N. Engl. J. Med. 313:1256-1262; 1985.
58. Bradbear, R. A.; Bain, C.; Siskind, V.; Schofield, F. D.; Webb, S.; Azelsen, E. M.; Halliday, J. W.; Bassett, M. L.; Powell, L. W. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J. Natl. Cancer Inst. 75:81-84; 1985.
59. Hsing, A. W.; McLaughlin, J. K.; Olsen, J. H.; Mellemkjar, L.; Wacholder, S.; Fraumeni, J. F., Jr. Cancer risk following primary hemochromatosis: A population-based cohort study in Denmark. Int. J. Cancer 60:160-162; 1995.
60. Fargion, S.; Fracanzani, A. L.; Piperno, A.; Braga, M.; D'Alba, R.; Ronchi, G.; Fiorelli, G. Prognostic factors for hepatocellular carcioma in genetic hemochromatosis. Hepatology 20:1426-1431; 1994.
61. Niedereau, C.; Strohmeyer, G.; Stremmel, W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv. Exp. Med. Biol. 356:293-302; 1994.
62. Ammann, R. W.; Muller, E.; Bansky, J.; Schuler, G.; Hacki, W. H. High incidence of extrahepatic carcinomas in idiopathic hemochromatosis. Scand. J. Gasrtoenterol. 15:733-736; 1980.
63. Tiniakos, G.; Williams, R. Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic hemochromatosis. Appl. Pathol. 6:128-138; 1988.
64. Fellows, I. W.; Stewart, M.; Jeffcoate, W. J.; Smith, P. G. Hepatocellular carcinoma in primary hemochromatosis in the absence of cirrhosis. Gut 29:1603-1609; 1988.
65. Kew, M. D. Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: ocurrence in noncirrhotic patients. Hepatology 6:1086-1087; 1990.
66. Blumberg, R. S.; Chopra, S.; Ibrahim, R.; Crawford, J.; Farraye, F. A.; Zeldis, J. R.; Berman, M. D. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology 95:1399-1402; 1988.
67. Bacon, B. R.; Britton, R. S. The pathology of hepatic iron overload: A free radical-mediated process? Hepatology 11:127-137; 1990.
68. Grootveld, M.; Bell, J. D.; Halliwell, B.; Aruoma, O. I.; Bomford, A.; Sadler, P. J. Nontransferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis: Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J. Biol. Chem. 264:4417-4422; 1989.
69. Toyokuni, S.; Sagripanti, J.-L. Induction of oxidative single and double strand breaks in DNA by ferric citrate. Free Radic. Biol Med. 15:117-123; 1993.
70. Mossman, B. T.; Bignon, J.; Corn, M.; Seaton, A.; Gee, J. B. L. Asbestos: Scientific developments and implications for public policy. Science 247:294-301; 1990.
71. Rosenthal, G. J.; Germolec, D. R.; Blazka, M. E.; Corsini, E.; Simeonova, P.; Pollock, P.; Kong, L.-Y.; Kwon, J.; Luster, M. I. Asbestos stimulates IL-8 production from human lung epithelial cells. J. Immunol. 153:3237-3244; 1994.
72. Lund, L. G.; Aust, A. E. Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DNA single-strand breaks in phi X174 RFI DNA. Carcinogenesis 13:637-642; 1992.
73. Adachi, S.; Yoshida, S.; Kawamura, K.; Takahashi, M.; Uchida, H.; Odagiri, Y.; Takemoto, K. Inductions of oxidative DNA damage and mesothelioma by crocidolite, with special reference to the presence of iron inside and outside of asbestos fiber. Carcinogenesis 15:753-758; 1994.
74. Mahmood, N.; Khan, S. G.; Athar, M.; Rahman, Q. Differential role of hydrogen peroxide and organic peroxides in augmenting asbestos-mediated DNA damage: Implications for asbestos induced carcinogenesis. Biochem. Biophys. Res. Commun. 200:687-694; 1994.
75. Takeuchi, T.; Morimoto, K. Crocidolite asbestos increased 8-hydroxydeoxyguanosine levels in cellular DNA of a human promyelocytic leukemia cell line, HL60. Carcinogenesis 15:635-639; 1994.
76. Kamp, D. W.; Graceffa, P.; Pryor, W. A.; Weitzman, S. A. The role of free radicals in asbestos-induced diseases. Free Radic. Biol. Med. 12:293-315; 1992.
77. Heintz, N. H.; Janssen, Y. N.; Mossman, B. T. Persistent induction of c-fos and c-jun expression by asbestos. Proc. Natl. Acad. Sci. USA 90:3299-3303; 1993.
78. Richmond, H. G. Induction of sarcoma in the rat by iron-dextran complex. Br. Med. J. i:947-949; 1959.
79. Okada, S.; Midorikawa, O. Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn. Arch. Intern. Med. 29: 485-491; 1982.
80. Ebina, Y.; Okada, S.; Hamazaki, S.; Ogino, F.; Li, J.-L.; Midorikawa, O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitriotriacetate complexes in rats. J. Natl. Cancer Inst. 76:107-113; 1986.
81. Li, J.-L.; Okada, S.; Hamazaki, S.; Ebina, Y.; Midorikawa, O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res. 47:1867-1869; 1987.
82. Mottola, H. A. Nitrilotriacetic acid as a chelating agent: Applications, toxicology, and bio-environmental impact. Toxicol. Environ. Chem. Rev. 71:99-161; 1974.
83. Anderson, R. L.; Bishop, W. E.; Campbell, R. L. A review of the environmental and mammalian toxicology of nitrilotriacetic acid. Crit. Rev. Toxicol. 15:1-102; 1985.
84. Bates, G. W.; Schlabach, M. R. The reaction of ferric salts with transferrin. J. Biol. Chem. 248:3228-3232; 1973.
85. Awai, M.; Narasaki, M.; Yamanoi, Y.; Seno, S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate: A model of experimental hemochromatosis. Am. J. Pathol. 95:663-674; 1979.
86. Maekawa, A.; Onodera, H.; Tanigawa, H.; Funita, K.; Kodama, Y.; Horiuchi, S.; Hayashi, Y. Neoplastic and nonneoplastic lesions in aging Slc:Wistar rats. J. Toxicol. Sci. 8:279-290; 1983.
87. Okada, S.; Hamazaki, S.; Ebina, Y.; Li, J.-L.; Midorikawa, O. Nephrotoxicity and its prevention by vitamin E on ferric nitrilotriacetate-promoted lipid peroxidation. Biochim. Biophys. Acta 922:28-33; 1987.
88. Hamazaki, S.; Okada, S.; Li, J.-L.; Toyokuni, S.; Midorikawa, O. Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate. Arch. Biochem. Biophys. 272:10-17; 1989.
89. Nishiyama, Y.; Suwa, H.; Okamoto, K.; Fukumoto, M.; Hiai, H.; Toyouni, S. Low incidence of point mutations in H-, K- and N-ras oncogenes an p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn. J. Cancer Res. 86:1150-1158; 1995.
90. Akiyama, T.; Hamazaki, S.; Okada, S. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate. Jpn. J. Cancer Res 86:1143-1149; 1995.
91. Okada, S.; Hamazaki, S.; Toyokuni, S.; Midorikawa, O. Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats. Br. J. Cancer 60:708-711; 1989.
92. Hamazaki, S.; Okada, S.; Toyokuni, S.; Midorikawa, O. Thiobarbituric acid-reactive substance formation of rat kidney brush border membrane vesicles induced by ferric nitrilotriacetate. Arch. Biochem. Biophys. 274:348-354; 1989.
93. Toyokuni, S.; Okada, S.; Hamazaki, S.; Minamiyama, Y.; Yamada, Y.; Liang, P.; Fukunaga, Y.; Midorikawa, O. Combined histochemical and biochemical analysis of sex hormone depen-dence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice. Cancer Res. 50:5574-5580; 1990.
94. Okada, S.; Minamiyama, Y.; Hamazaki, S.; Toyokuni, S.; Sotomatsu, A. Glutathione cycle dependency of ferric nitrilotriacetate-induced lipid peroxidation in mouse proximal renal tubules. Arch. Biochem. Biophys. 301:138-142; 1993.
95. Toyokuni, S.; Sagripanti, J.-L. DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis. Carcinogenesis 14:223-227; 1993.
96. Yamada, M.; Awai, M.; Okigaki, T. Rapid in vitro transformation system for liver epithelial cells by iron chelate, Fe-NTA. Cytotechnology 3:149-156; 1990.
97. Liu, M.; Okada, S. Induction of free radicals and tumors in the kidneys of Wistar rats by ferric ethylenediamine-N,N′-diacetate. Carcinogenesis 15:2817-2821; 1994.
98. IARC Working Group on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Nickel and nickel compounds. In: IARC monographs on the evaluation of the carcinogenic risk of chemicals to man, vol. 11. Lyon: IARC; 1976:75-112.
99. Chovil, A.; Sutherland, R. B.; Halliday, M. Respiratory cancer in a cohort of nickel sinter plant workers. Br. J. Ind. Med. 38:327-333; 1981.
100. Gilman, J. P. W. Metal carcinogenesis. II. A study on the carcinogenic activity of cobalt, copper, iron, and nickel compounds. Cancer Res. 22:158-162; 1962.
101. Sunderman, F. W., Jr.; Maenza, R. M. Comparisons of carcinogenicities of nickel compounds in rats. Res. Commun. Chem. Pathol. Pharmacol. 14:319-330; 1976.
102. Sunderman, F. W., Jr. Recent advances in metal carcinogenesis. Ann. Clin. Lab. Sci. 14:93-122; 1984.
103. Sunderman, F. W., Jr.; Maenza, R. M.; Hopfer, S. M.; Mitchell, J. M.; Allpass, P. R.; Damjanov, I. Induction of renal cancers in rats by intrarenal injection of nickel subsulfide. J. Environ. Pathol. Toxicol. 2:1511-1527; 1979.
104. Higinbotham, K. G.; Rice, J. M.; Diwan, B. A.; Kasprzak, K. S.; Reed, C. D.; Perantoni, A. O. GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA. Cancer Res. 52:4747-4751; 1992.
105. Mon, M.; Hattori, A.; Sawaki, M.; Tsuzuki, N.; Sawada, N.; Oyamada, M.; Sugawara, N.; Enomoto, A. The LEC rat: A model for human hepatitis, liver cancer, and much more. Am. J. Pathol 144:200-204; 1994.
106. Wu, J.; Forbes, J. R.; Chen, H. C.; Cox, D. W. The LEC rat has a deletion in the copper tranporting ATPase gene homologous to the Wilson disease gene. Nat. Genet. 7:541-545; 1994.
107. Li, Y.; Togashi, Y.; Sato, S.; Emoto, T.; Kang, J.-H.; Takeichi, N.; Kobayashi, H.; Kojima, Y.; Une, Y.; Uchino, J. Abnormal copper accumulation in noncancerous and cancerous liver tissue of LEC rats developing hereditary hepatitis and spontaneous hepatoma. Jpn. J. Cancer Res. 82: 490-492; 1991.
108. Sugawara, N.; Sugawara, C.; Katakura, M.; Takahashi, H.; Mori, M. Copper metabolism in the LEC rat: Involvement of induction of metallothionein and deposition of zinc and iron. Experimentia 47:1060-1063; 1991.
109. Kato, J.; Kohgo, Y.; Sugawara, N.; Katsuki, S.; Shintani, N.; Fujikawa, K.; Miyazaki, E.; Kobune, M.; Takeichi, N.; Niitsu, Y. Abnormal hepatic iron accumulation in LEC rats. Jpn. J. Cancer Res. 84:219-222; 1993.
110. Toyokuni, S.; Okada, S.; Hamazaki, S.; Fujioka, M.; Li, J.-L.; Midorikawa, O. Cirrhosis of the liver induced by cupric nitrilotriacetate in Wistar rats: An experimetnal model of copper toxicosis. Am. J. Pathol. 134:1263-1274; 1989.
111. Smith, A. G.; Cabrai, J. R. P.; Carthew, P.; Francis, J. E.; Manson, M. M. Carcinogenicity of iron in conjunction with a chlorinated environmental chemical, hexachlorobenzene, in C57BL/10ScSn mice. Int. J. Cancer 43:492-496; 1989.
112. Thompson, H. J.; Kennedy, K.; Juzefyk, J. Effect of dietary iron defficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 12:111-114; 1991.
113. Hann, H.-W. L.; Stahlhut, M. W.; Menduke, H. Iron enhances tumor growth: Observation on spontaneous mammary tumors in mice. Cancer 68:2407-2410; 1991.
114. Yoshiji, H.; Nakane, D.; Kinugasa, T.; Matsuzaki, M.; Denda, A.; Tsujii, T.; Konishi, Y. Inhibitory effect of dietary iron deficiency on the induction of putative preneoplastic foci in rat liver with diethylnitrosamine promoted by phenobarbital. Br. J. Cancer 64:839-842; 1991.
115. Stal, P.; Hulterantz, R.; Moller, L.; Eriksson, L. C. The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis. Hepatology 21:521-528; 1995.
116. Hamazaki, S.; Okada, S.; Ebina, Y.; Midorikawa, O. Acute renal failure and glucosuria induced by ferric nitrilotriacetate in rats. Toxicol. Appl. Pharmacol 77:267-274; 1985.
117. Hamazaki, S.; Okada, S.; Ebina, Y.; Fujioka, M.; Midorikawa, O. Nephrotoxicity of ferric nitrilotriacetate: An electron-microscopic and metabolic study. Am. J. Pathol. 123:343-350; 1986.
118. Okada, S.; Fukunaga, Y.; Hamazaki, S.; Yamada, Y.; Toyokuni, S. Sex differences in the localization and severity of ferric nitrilotriacetate-induced lipid peroxidation in the mouse kidney. Acta Pathol. Jpn. 41:221-226; 1991.
119. Hamazaki, S.; Okada, S.; Ebina, Y.; Li, J.-L.; Midorikawa, O. Effect of dietary vitamin E on ferric nitrilotriacetate-induced nephrotoxicity in rats. Toxicol. Appl. Pharmacol. 92:500-506; 1988.
120. Toyokuni, S.; Uchida, K.; Okamoto, K.; Hattori-Nakakuki, Y.; Hiai, H.; Stadtman, E. R. Formation of 4-hydroxy-2-nonenalmodified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl. Acad. Sci. USA 91:2616-2620; 1994.
121. Toyokuni, S.; Uchida, K.; Okamoto, K.; Hattori-Nakakuki, Y.; Hiai, H.; Stadtman, E. R. Formation of 4-hydroxy-2-nonenalmodified proteins in the renal proximal tubules of rats tretated with a renal carcinogen, ferric nitrilotriacetate. In: VIth international conference on superoxide and superoxide dismutase, Kyoto, October 11-15, 1993. Excerpta Medica International Congress Series 1058. Amsterdam: Elsevier; 1994:171-172.
122. Uchida, K.; Fukuda, A.; Kawakishi, S.; Hiai, H.; Toyokuni, S. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch. Biochem. Biophys. 317:405-411; 1995.
123. Uchida, K.; Stadtman, E. R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. USA 89:4544-4548; 1992.
124. Uchida, K.; Szweda, L. I.; Chae, H.-Z.; Stadtman, E. R. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA 90:8742-8746; 1993.
125. Uchida, K.; Stadtman, E. R. Covalent attachment of 4-hydroxy-nonenal to glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 268:6388-6393; 1993.
126. Toyokuni, S.; Miyake, N.; Hiai, H.; Hagiwara, M.; Kawakishi, S.; Osawa, T.; Uchida, K. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett. 359:189-191; 1995.
127. Esterbauer, H.; Zollner, H.; Lang, J. Metabolism of lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochem. J. 228:363-373; 1985.
128. Esterbauer, H.; Schauur, J. S.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128; 1991.
129. Grune, T.; Siems, W. G.; Zollner, H. G.; Esterbauer, H. Metaboism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages. Cancer Res. 54:5231-5235; 1994.
130. Dizdaroglu, M. Chemical determination of free radical-induced damage to DNA. Free Radic. Biol. Med. 10:225-242; 1991.
131. Schneider, J. E.; Browning, M. M.; Zhu, X.; Floyd, R. A. Ascorbate/iron mediation of hydroxyl free radical damage to pBR322 plasmid DNA. Free Radic. Biol. Med. 5:287-295; 1988.
132. Tachion, P. Ferric and cupric ions requirement for DNA single-strand breakage by hydrogen peroxide. Free Radic. Res. Commun. 7:1-10; 1989.
133. Aruoma, O. I.; Halliwell, B.; Dizdaroglu, M. Damage to the base in DNA induced by hydrogen peroxide and ferric iron chelates. J. Biol. Chem. 264:20509-20512; 1989.
134. Nackerdien, Z.; Rao, G.; Cacciuttolo, M. A.; Gajewski, E.; Dizdaroglu, M. Chemical nature of DNA-protein cross-links produced in mammalian chromatin by hydrogen peroxide in the presence of iron or copper ions. Biochemistry 30:4873-4879; 1991.
135. Umemura, T.; Sai, K.; Takagi, A.; Hasegawa, R.; Kurokawa, Y. Oxidative DNA damage, lipid peroxidation and nephrotoxicity induced in the rat kidney after ferric nitrilotriacetate administration. Cancer Lett. 54:95-100; 1990.
136. Umemura, T.; Sai, K.; Takagi, A.; Hasegawa, R.; Kurokawa, Y. Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis 11:345-347; 1990.
137. Toyokuni, S.; Mori, T.; Dizdaroglu, M. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int. J. Cancer 57:123-128; 1994.
138. Toyokuni, S.; Mori, T.; Hiai, H.; Dizdaroglu, M. Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Int. J. Cancer 62:309-313; 1995.
139. Wagner, J. R.; Hu, C.-C.; Ames, B. N. Endogenous oxidative damage of deoxycytidine in DNA. Proc. Natl. Acad. Sci. USA 89:3380-3384; 1992.
140. Hayes, R. C.; Petrullo, L. A.; Huang, H.; Wallace, S. S.; LeClerc, J. E. Oxidative damage in DNA: Lack of mutagenicity by thymine glycol lesions. J. Mol. Biol. 201:239-246; 1988.
141. Basu, A. K.; Loechler, E. L.; Leadon, S. A.; Essigmann, J. M. Genetic effets of thymine glycol: Site-specific mutagenesis and molecular modeling studies. Proc. Natl. Acad. Sci. USA 86:7677-7681; 1989.
142. Steenken, S. Purine bases, nucleosides, and nucleotides: Aqueous solution redox chemistry and transformation reactions of their radical reactions and e and OH adducts. Chem. Rev. 89:503-520; 1989.
143. Guschlbauer, W.; Duplaa, A.-M.; Guy, A.; Teoule, R.; Fazakerley, G. V. Structure and in vitro replication of DNA templates containing 7, 8-dihydro-8-oxoadenine. Nucleic Acids Res. 19:1753-1758; 1991.
144. Wood, M. L.; Esteve, A.; Morningstar, M. L.; Kuziemko, G. M.; Essigmann, J. M. Genetic effects of oxidative DNA damage: Comparative mutagenesis of 7,8-dihydro-8-oxoguanine and 7,8-dihydro-8-oxoadenine in Escherichia coli. Nucleic Acids Res. 20:6023-6032; 1992.
145. Kuchino, Y.; Mori, F.; Kasai, H.; Inoue, H.; Iwai, S.; Miura, K.; Ohtsuka, E.; Nishimura, S. DNA templates containing 8-hydroxydeoxyguanosine are misread both at the modified base and at adjacent residues. Nature 327:77-79; 1987.
146. Shibutani, S.; Takeshita, M.; Grollman, A. P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349:431-434; 1991.
147. Breimer, L. H. Repair of DNA damage induced by reactive oxygen species. Free Radic. Res. Commun. 14:159-171; 1991.
148. Kasai, H.; Nishimura, S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 12:2137-2145; 1984.
149. Cheng, K. C.; Cahill, D. S.; Kasai, H.; Nishimura, S.; Loeb, L. A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G to T and A to C substitutions, J. Biol. Chem. 267:166-172; 1992.
150. Wood, M. L.; Dizdaroglu, M.; Gajewski, E.; Essigmann, J. M. Mechanistic studies of ionizing radiation and oxidative muta-genesis: Genetic effect of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry 29:7024-7032; 1990.
151. Floyd, R. A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11:1447-1450; 1990.
152. Loft, S.; Vistisen, K.; Ewertz, M.; Tjonneland, A.; Overvad, K.; Poulsen, H. E. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: Influence of smoking, gender and body mass index. Carcinogenesis 13:2241-2247; 1992.
153. Loft, S.; Fischer Nielsen, A.; Jeding, I. B.; Vistisen, K.; Poulsen, H. E. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J. Toxicol. Environ. Health 40:391-404; 1993.
154. Park, J.-W.; Floyd, R. A. Lipid peroxidation products mediate the formation of 8-hydroxydeoxyguanosine in DNA. Free Radic. Biol. Med. 12:245-250; 1992.
155. Shields, P. G.; Harris, C. C. Molecular epidemiology and the genetics of environmental cancer. JAMA 266:681-687; 1991.
156. McBride, T. J.; Preston, B. D.; Loeb, L. A. Mutagenic spectrum resulting from DNA damage by oxygen radicals. Biochemistry 30:207-213; 1991.
157. Reid, T. M.; Loeb, L. A. Tandem double CC to TT mutations are produced by reactive oxygen species. Proc. Natl. Acad. Sci. USA 90:3904-3907; 1993.
158. Nakatsuka, S.; Tanaka, H.; Namba, M. Mutagenic effects of ferric nitrilotriacetate (Fe-NTA) on V79 Chinese hamster cells and its inhibitory effects on cell-cell communication. Carcinogenesis 11:257-260; 1990.
159. Toyokuni, S.; Sagripanti, J.-L.; Hitchins, V. M. Cytotoxic and mutagenic effects of ferric nitrilotriacetate on L5178Y mouse lymphoma cells. Cancer Lett. 88:157-162; 1995.
160. Tagaya, Y., Wakasugi, H.; Masutani, H.; Nakamura, H.; Iwata, S.; Mitsui, A.; Fujii, S.; Wakasugi, N.; Tursz, T.; Yodoi, J. Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: Involvement of dithiol related reduction. Mol. Immunol. 27:1279-1289; 1990.
161. Halliwell, B. How to characterize a biological antioxidant. Free Radic. Res. Commun. 9:1-32; 1990.
162. Dabbagh, A. J.; Mannion, T.; Lynch, S. M.; Frei, B. The effect of iron overload on rat plasma and liver oxidant status in vivo. Biochem. J. 300(Part 3):799-803; 1994.
163. Bonkovsky, H. L.; Healey, J. F.; Lincoln, B.; Bacon, B. R.; Bishop, D. F.; Elder, G. H. Hepatic heme synthesis in a new model of experimental hemochromatosis: Studies in rats fed finely divided elemental iron. Hepatology 7:1195-1203; 1987.
164. Kawabata, T.; Ogino, T.; Awai, M. Protective effects of glutathione against lipid peroxidation in chronically iron-loaded mice. Biochim. Biophys. Acta 1004:89-94; 1989.
165. Fletcher, L. M.; Roberts, F. D.; Irving, M. G.; Powell, L. W.; Halliday, J. W. Effects of iron loading on free radical scavenging enzymes and lipid peroxidation in rat liver. Gastroenterology 97:1011-1018; 1989.
166. Nakagawa, K.; Saijo, N.; Tsuchida, S.; Sakai, M.; Tsunokawa, Y.; Yokata, J.; Muramatsu, M.; Terada, M.; Tew, K. D. Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines. J. Biol. Chem. 265:4296-4301; 1990.
167. Tsuchida, S.; Sekine, Y.; Shineha, R.; Nishihira, T.; Sato, K. Elevation of placental S-transferase form (GST-pi) in tumor tissues and the level in sera of patients with cancer. Cancer Res. 49:5225-5229; 1989.
168. Batist, G.; Tulpule, A.; Sinha, B. K.; Katki, A. G.; Meyers, C. E.; Cowan, K. H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem. 261:15544-15549; 1986.
169. Mulder, T. P. J.; Verspaget, H. W.; Sier, C. F. M.; Roelofs, H. M. J.; Ganesh, S.; Griffioen, G.; Peters, W. H. M. Glutathione S-transferase π in colorectal tumors is predicative for overall survival. Cancer Res. 55:2696-2702; 1995.
170. Toyokuni, S.; Okamoto, K.; Yodoi, J.; Hiai, H. Hypothesis: Persistent oxidative stress in cancer. FEBS Lett. 358:1-3; 1995.
171. Cerutti, P.; Amstad, P.; Larsson, R.; Shar, G.; Krupitza, G. Mechanisms of oxidant carcinogenesis. Prog. Clin. Biol. Res. 347:183-186; 1990.
172. Crawford, D.; Zbinden, I.; Amstad, P.; Cerutti, P. Oxidant stress induces the protooncogenes c-fos and c-myc in mouse epidermal cells. Oncogene 3:27-32; 1988.
173. Weinberg, J. B.; Hibbs, J. B., Jr. Endocytosis of red blood cells or
174. Green, R.; Esparza, I.; Schreiber, R. Iron inhibits the nonspecific tumoricidal activity of macrophages. Ann. NY Acad. Sci. 114:18733-22341; 1988.
175. Djeka, A.; Broch, J. H. Effect of transferrin, lactoferrin and chelated iron on human T-lymphocytes. Br. J. Haematol. 80:235-241; 1992.
176. Weinberg, E. D. Iron withholding; A defense against infection and neoplasia. Physiol. Rev. 64:64-102; 1984.
177. Weinberg, E. D. Roles of iron in neoplasia: Promotion, prevemtion, and therapy. Biol. Trace Element Res. 34:123-140; 1992.
178. Guyton, K. Z.; Kensler, T. W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull. 49:523-544; 1993.
179. Feig, D. I.; Reid, T. M.; Loeb, L. A. Reactive oxygen species in tumorigenesis. Cancer Res. 54:1890s-1894s; 1994.
180. Loft, S.; Astrup, A.; Buemann, B.; Poulsen, H. E. Oxidative DNA damage correlates with oxygen consumption in humans. FASEB J. 8:534-537; 1994.